TRASTUZUMAB UPTAKE IN HER2-POSITIVE BREAST CANCER PATIENTS: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES

被引：0
|
作者：
Martin, A. P. [1 ]
Downing, J. [1 ]
Collins, B. [2 ]
Cochrane, M. [3 ]
Francis, B. [2 ]
Haycox, A. [2 ]
Alfirevic, A. [1 ,2 ]
Pirmohamed, M. [1 ]
机构：
[1] Univ Liverpool, NIHR CLAHRC NWC, Liverpool, Merseyside, England
[2] Univ Liverpool, Liverpool, Merseyside, England
[3] Liverpool John Moores Univ, Liverpool, Merseyside, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.248
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN201
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [1] Trastuzumab uptake in HER2-positive breast cancer patients: a systematic review and meta-analysis of observational studies
    Martin, Antony P.
    Downing, Jennifer
    Cochrane, Madeleine
    Collins, Brendan
    Francis, Ben
    Haycox, Alan
    Alfirevic, Ana
    Pirmohamed, Munir
    [J]. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2018, 130 : 92 - 107
  • [2] Trastuzumab combined to neoadjuvant chemotherapy in patients with HER2-positive breast cancer: A systematic review and meta-analysis
    Valachis, Antonis
    Mauri, Davide
    Polyzos, Nikolaos P.
    Chlouverakis, Grigoris
    Mavroudis, Dimitrios
    Georgoulias, Vassilios
    [J]. BREAST, 2011, 20 (06): : 485 - 490
  • [3] Trastuzumab deruxtecan for HER2-positive breast cancer brain metastasis: A systematic review and meta-analysis
    Michelon, I. F.
    Vilbert, M. Silveira
    Marinho, A. D.
    Castro, C. E. D. R.
    Dacoregio, M. I.
    Stecca, C.
    Soares, L. R.
    [J]. ANNALS OF ONCOLOGY, 2023, 34 : S357 - S357
  • [4] Clinical therapeutic effects of trastuzumab in HER2-positive breast cancer patients A protocol for systematic review and meta-analysis
    Tong, Chuanming
    Wang, Chuan
    Yang, Kun
    [J]. MEDICINE, 2021, 100 (17) : E25685
  • [5] Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
    Wilson, Florence R.
    Coombes, Megan E.
    Brezden-Masley, Christine
    Yurchenko, Mariya
    Wylie, Quinlan
    Douma, Reuben
    Varu, Abhishek
    Hutton, Brian
    Skidmore, Becky
    Cameron, Chris
    [J]. SYSTEMATIC REVIEWS, 2018, 7
  • [6] Herceptin® (trastuzumab) in HER2-positive early breast cancer: a systematic review and cumulative network meta-analysis
    Florence R. Wilson
    Megan E. Coombes
    Christine Brezden-Masley
    Mariya Yurchenko
    Quinlan Wylie
    Reuben Douma
    Abhishek Varu
    Brian Hutton
    Becky Skidmore
    Chris Cameron
    [J]. Systematic Reviews, 7
  • [7] Trastuzumab biosimilars vs trastuzumab originator in the treatment of HER2-positive breast cancer: a systematic review and network meta-analysis
    Liu, Tong
    Liu, Duo
    Jin, Yao
    Dong, Mei
    [J]. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY, 2022, 44 (06) : 809 - 815
  • [8] Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
    Wilson, Florence R.
    Coombes, Megan E.
    Wylie, Quinlan
    Yurchenko, Mariya
    Brezden-Masley, Christine
    Hutton, Brian
    Skidmore, Becky
    Cameron, Chris
    [J]. SYSTEMATIC REVIEWS, 2017, 6
  • [9] Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis
    Florence R. Wilson
    Megan E. Coombes
    Quinlan Wylie
    Mariya Yurchenko
    Christine Brezden-Masley
    Brian Hutton
    Becky Skidmore
    Chris Cameron
    [J]. Systematic Reviews, 6
  • [10] Adjuvant trastuzumab regimen for HER2-positive early-stage breast cancer: a systematic review and meta-analysis
    Genuino, Anne Julienne
    Chaikledkaew, Usa
    The, Due Ong
    Reungwetwattana, Thanyanan
    Thakkinstian, Ammarin
    [J]. EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2019, 12 (08) : 815 - 824
12345